This transcript has been edited for clarity. Vallerie McLaughlin, MD: Hello and welcome to this Medscape InDiscussion on pulmonary arterial hypertension (PAH). Our topic today is the very important ...
Can a one-minute sit-to-stand test predict long-term outcomes in pulmonary hypertension? New data suggest it can. Read more.
Panelists discuss how disease progression monitoring requires integrating multiple data points including symptoms, six-minute walk tests, biomarkers like BNP/NT-proBNP, and imaging studies, with risk ...
Panelists discuss how riociguat targets the nitric oxide pathway and is approved for both Group 1 PAH and Group 4 chronic thromboembolic pulmonary hypertension, with specific patient selection ...
Women with preeclampsia had significantly higher median NT-proBNP levels compared with those with other hypertensive ...
Novel Laser Intravascular Lithotripsy (L-IVL) System for Calcified Coronary Lesions: Procedural Success and Imaging Outcomes from the First-in-Human Experience (FastWave Medical) Receive the the ...
An expert panel developed practical flowcharts to help U.S. healthcare providers with the diagnosis and treatment of ...
Elevated maternal uric acid levels during early to mid-gestation are independently associated with an increased risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results